“…146 -148 What effect potent combination antiretroviral therapy will have in altering the clinical course of AIDS-related neoplasms is uncertain and necessitates long-term study. 149 Recently, I described a patient with symptomatic pulmonary KS, a CD4ϩ cell count Ͻ 50/L, and an elevated HIV viral load. 150 He declined recommendations to receive chemotherapy, but reluctantly agreed to begin HAART.…”